Viewing Study NCT02897050


Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2026-01-04 @ 5:09 PM
Study NCT ID: NCT02897050
Status: SUSPENDED
Last Update Posted: 2022-04-20
First Post: 2016-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module